JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB39670

Anti-FOXO1A antibody

4

(13 Reviews)

|

(113 Publications)

Rabbit Polyclonal FOXO1A antibody. Suitable for ELISA, WB, IHC-P and reacts with Human samples. Cited in 113 publications. Immunogen corresponding to Synthetic Peptide within Human FOXO1.

View Alternative Names

FKHR, FOXO1A, FOXO1, Forkhead box protein O1, Forkhead box protein O1A, Forkhead in rhabdomyosarcoma

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXO1A antibody (AB39670)
  • IHC-P

PubMed

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXO1A antibody (AB39670)

Tissue microarray analysis of FOXO1 expression

Representative images of FOXO1 expression in normal brain tissue (C, ×200); grade II diffuse astrocytoma (D, ×200); grade III anaplastic astrocytoma (E, ×200) and grade IV glioblastoma (F, ×200).

FOXO1 was detected using ab39670 at 1/200 dilution. The tissue microarray was contructed from paraffin-embedded human brain tissue samples.

(After Figure 1 of Chen et al).

Chen, C. et al PLoS One. 2013 Jul 9;8(7):e69260. doi: 10.1371/journal.pone.0069260. Print 2013 Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXO1A antibody (AB39670)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXO1A antibody (AB39670)

Paraffin-embedded human brain tissue stained for FOXO1 with ab39670 at 1/50 dilution in immunohistochemical analysis. The right hand image was obtained following blocking with the immunizing peptide.

Western blot - Anti-FOXO1A antibody (AB39670)
  • WB

Unknown

Western blot - Anti-FOXO1A antibody (AB39670)

10% gel.

Running conditions : 60v, 30min; 120v 60min

Transfer conditions : 150mA 120min Nitrocellulose membrane.

Blocking conditions : 5% non-fat milk in TBST, RT, 90min.

Primary antibody incubation : 4℃, overnight.

Washing condition : 5 ml TBST, 4 x 5min.

Lanes 1 - 3:

Western blot - Anti-FOXO1A antibody (ab39670) at 1/500 dilution

Lanes 4 - 5:

Anti-FOXO1A (phospho S319) antibody (<a href='/en-us/products/unavailable/foxo1a-phospho-s319-antibody-ab38516'>ab38516</a>) at 1/500 dilution

Lane 1:

293 Cell extract at 30 µg

Lanes 2 - 5:

HeLa Cell extract at 30 µg

Secondary

All lanes:

Alkaline Phosphatase AffiniPure Goat Anti-Rabbit IgG (H+L)

Predicted band size: 69 kDa

Observed band size: 70 kDa

false

Western blot - Anti-FOXO1A antibody (AB39670)
  • WB

AbReview16688****

Western blot - Anti-FOXO1A antibody (AB39670)

Primary diluted in PBS (BSA + 0.1% Tween20) and incubated with sample for 90 minutes at 20°C.

All lanes:

Western blot - Anti-FOXO1A antibody (ab39670) at 1/1000 dilution

All lanes:

Whole cell lysates prepared from human Jurkat cells at 200000 Cells

Secondary

All lanes:

HRP-conjugated donkey polyclonal to rabbit IgG at 1/2000 dilution

Predicted band size: 69 kDa

Observed band size: 45 kDa,50 kDa,70 kDa,80 kDa

true

Exposure time: 30s

This image is courtesy of an anonymous abreview.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB, ELISA

applications

Immunogen

Synthetic Peptide within Human FOXO1. The exact immunogen used to generate this antibody is proprietary information.

Q12778

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FOXO1A also known as forkhead box O1 FOXO1 or FOXO1 transcription factor is a protein with a molecular weight of approximately 70 kDa. It is an important transcription factor in the FOXO family responsible for regulating gene expression in response to environmental and physiological stimuli. FOXO1A predominantly localizes in the nucleus but can translocate to the cytoplasm under certain conditions. Expression of FOXO1A occurs in various tissues including liver adipose tissue and pancreatic islets indicating its broad functional roles in different organs.
Biological function summary

FOXO1A acts as a regulator of metabolic pathways apoptosis and cell cycle regulation. Its role in glucose metabolism stands out as a critical function where it influences insulin signaling and glucose homeostasis. FOXO1A can also form complexes with other transcription factors like PPARγ enhancing its regulatory capacity. Interactions within these complexes dictate the transcriptional outcomes influencing cellular responses to stress and growth signals.

Pathways

The FOXO1 transcription factor plays a critical role in the insulin signaling and PI3K-Akt pathway. These pathways are essential for maintaining energy balance and cellular survival. FOXO1A interacts with proteins like Akt which phosphorylates FOXO1A resulting in its cytoplasmic sequestration and subsequent inactivation. This regulation is vital for insulin-mediated glucose uptake and overall metabolic homeostasis preserving cellular functions under fluctuating nutrient conditions.

Aberrant FOXO1A activity is associated with type 2 diabetes and certain cancers. Dysregulation leads to impaired insulin signaling and glucose metabolism contributing to insulin resistance and hyperglycemia in diabetes. In cancer altered FOXO1A expression affects apoptosis and cell proliferation influencing tumor progression and survival. Associations with proteins such as Akt and PPARγ in these conditions further exemplify its network in disease mechanisms highlighting its potential as a therapeutic target.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription factor that is the main target of insulin signaling and regulates metabolic homeostasis in response to oxidative stress (PubMed : 10358076, PubMed : 12228231, PubMed : 15220471, PubMed : 15890677, PubMed : 18356527, PubMed : 19221179, PubMed : 20543840, PubMed : 21245099). Binds to the insulin response element (IRE) with consensus sequence 5'-TT[G/A]TTTTG-3' and the related Daf-16 family binding element (DBE) with consensus sequence 5'-TT[G/A]TTTAC-3' (PubMed : 10358076). Activity suppressed by insulin (PubMed : 10358076). Main regulator of redox balance and osteoblast numbers and controls bone mass (By similarity). Orchestrates the endocrine function of the skeleton in regulating glucose metabolism (By similarity). Also acts as a key regulator of chondrogenic commitment of skeletal progenitor cells in response to lipid availability : when lipids levels are low, translocates to the nucleus and promotes expression of SOX9, which induces chondrogenic commitment and suppresses fatty acid oxidation (By similarity). Acts synergistically with ATF4 to suppress osteocalcin/BGLAP activity, increasing glucose levels and triggering glucose intolerance and insulin insensitivity (By similarity). Also suppresses the transcriptional activity of RUNX2, an upstream activator of osteocalcin/BGLAP (By similarity). Acts as an inhibitor of glucose sensing in pancreatic beta cells by acting as a transcription repressor and suppressing expression of PDX1 (By similarity). In hepatocytes, promotes gluconeogenesis by acting together with PPARGC1A and CEBPA to activate the expression of genes such as IGFBP1, G6PC1 and PCK1 (By similarity). Also promotes gluconeogenesis by directly promoting expression of PPARGC1A and G6PC1 (PubMed : 17024043). Important regulator of cell death acting downstream of CDK1, PKB/AKT1 and STK4/MST1 (PubMed : 18356527, PubMed : 19221179). Promotes neural cell death (PubMed : 18356527). Mediates insulin action on adipose tissue (By similarity). Regulates the expression of adipogenic genes such as PPARG during preadipocyte differentiation and, adipocyte size and adipose tissue-specific gene expression in response to excessive calorie intake (By similarity). Regulates the transcriptional activity of GADD45A and repair of nitric oxide-damaged DNA in beta-cells (By similarity). Required for the autophagic cell death induction in response to starvation or oxidative stress in a transcription-independent manner (PubMed : 20543840). Mediates the function of MLIP in cardiomyocytes hypertrophy and cardiac remodeling (By similarity). Positive regulator of apoptosis in cardiac smooth muscle cells as a result of its transcriptional activation of pro-apoptotic genes (PubMed : 19483080). Regulates endothelial cell (EC) viability and apoptosis in a PPIA/CYPA-dependent manner via transcription of CCL2 and BCL2L11 which are involved in EC chemotaxis and apoptosis (PubMed : 31063815).
See full target information FOXO1

Publications (113)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in pharmacology 16:1600435 PubMed40918528

2025

Gypenoside XLIX inhibiting PI3K/AKT/FOXO1 signaling pathway mediated neuronal mitochondrial autophagy to improve patients with ischemic stroke.

Applications

Unspecified application

Species

Unspecified reactive species

Yonglei Liu,Hongdie Mao,Zhengguang Sha,Jishuai Zhao,Hui Cai,Rong Xi,Zhenzhu Zhao,Xiaoling Yin,Lin Yang,Changyun Liu

Nature 646:697-706 PubMed40903586

2025

Amygdala-liver signalling orchestrates glycaemic responses to stress.

Applications

Unspecified application

Species

Unspecified reactive species

J R E Carty,K Devarakonda,R M O'Connor,A Krek,D Espinoza,M Jimenez-Gonzalez,A Alvarsson,R F Hampton,R Li,Y Qiu,S Petri,A Shtekler,A Rajbhandari,K Conner,M Bayne,D Garibay,J Martin,V Lehmann,L Wang,K Beaumont,I Kurland,G C Yuan,P J Kenny,S A Stanley

Nature cardiovascular research 4:801-820 PubMed40410415

2025

Angiopoietin-TIE2 feedforward circuit promotes PIK3CA-driven venous malformations.

Applications

Unspecified application

Species

Unspecified reactive species

Marle Kraft,Hans Schoofs,Milena Petkova,Jorge Andrade,Ana Rita Grosso,Rui Benedito,An-Katrien De Roo,Laurence M Boon,Miikka Vikkula,Friedrich G Kapp,René Hägerling,Michael Potente,Taija Mäkinen

Journal of bone oncology 50:100655 PubMed39850453

2025

Using β-Elemene to reduce stemness and drug resistance in osteosarcoma: A focus on the AKT/FOXO1 signaling pathway and immune modulation.

Applications

Unspecified application

Species

Unspecified reactive species

Shaochun Zhang,Zhijie Xing,Jing Ke

Signal transduction and targeted therapy 10:25 PubMed39837814

2025

Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8T and tumor cells.

Applications

Unspecified application

Species

Unspecified reactive species

Gui-Qi Zhu,Zheng Tang,Tian-Hao Chu,Biao Wang,Shi-Ping Chen,Chen-Yang Tao,Jia-Liang Cai,Rui Yang,Wei-Feng Qu,Yi Wang,Qian-Fu Zhao,Run Huang,Meng-Xin Tian,Yuan Fang,Jun Gao,Xiao-Ling Wu,Jian Zhou,Wei-Ren Liu,Zhi Dai,Ying-Hong Shi,Jia Fan

STAR protocols 6:103326 PubMed39799578

2025

Protocol for transcriptomic and epigenomic analyses of tip-like endothelial cells using scRNA-seq and ChIP-seq.

Applications

Unspecified application

Species

Unspecified reactive species

Shintaro Funasaki,Yuri Miyamura,Shunsuke Kamei,Akhinur Rahman,Masaya Yamazaki,Shingo Usuki,Keiichiro Yasunaga,Yorifumi Satou,Hiroto Ohguchi,Takashi Minami

American journal of clinical and experimental urology 12:64-87 PubMed38736619

2024

Urine-derived stem cells genetically modified with IGF1 improve muscle regeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Hualin Yi,Gang Chen,Shuai Qiu,Joshua T Maxwell,Guiting Lin,Tracy Criswell,Yuanyuan Zhang

iScience 27:109161 PubMed38444610

2024

FOXO1 stimulates tip cell-enriched gene expression in endothelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yuri Miyamura,Shunsuke Kamei,Misaki Matsuo,Masaya Yamazaki,Shingo Usuki,Keiichiro Yasunaga,Akiyoshi Uemura,Yorifumi Satou,Hiroto Ohguchi,Takashi Minami

Food & nutrition research 67: PubMed37850072

2023

Antidiabetic and antihyperlipidemic activities of . extract and the regulation of Akt phosphorylation, gluconeogenesis, and peroxisome proliferator-activated receptor α in streptozotocin-induced diabetic mice.

Applications

Unspecified application

Species

Unspecified reactive species

Shin-Ming Huang,Cheng-Hsiu Lin,Wen-Fang Chang,Chun-Ching Shih

Journal of animal science 101: PubMed37638641

2023

The FoxO1-ATGL axis alters milk lipolysis homeostasis through PI3K/AKT signaling pathway in dairy goat mammary epithelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Qiuya He,Liangjiahui Gao,Fuhong Zhang,Weiwei Yao,Jiao Wu,Ning Song,Jun Luo,Yong Zhang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com